Brexit for British Nationals in France

Dec 1, 2019 | Global

This article provides updates on what the Brexit transition means for British nationals residing in France.

On December 31, 2020, at midnight, the Brexit transition period will end. The United Kingdom (UK) will become a third country to the European Union (EU).

British nationals already residing in France can submit “Withdrawal Agreement” residence permit applications now. The request can be made on the internet. All British nationals already residing in France before December 31, 2020, are eligible to apply for a residence permit, in accordance with the provisions of the Brexit agreement signed between the UK and the EU. By June 30, 2021, all British nationals wishing to benefit from the provisions of the Brexit agreement to retain their rights to stay and work in France must have a French residence permit.

Applicants must upload documentation, including passport identity pages; proof establishing the date the applicant moved to France, such as a property certificate issued by a notary, a home insurance contract, a home insurance certificate or an employment contract; and documents relating to the specific situation of each applicant. For example, an employee must provide a copy of their most recent pay slip, while a student must provide proof of enrollment in a school or university. After completing these steps, the applicant will receive an application confirmation by email, with a reference number confirming the filing.

Once the file has been processed, an email will be sent to the candidate to make an appointment at the prefecture to finalize the file (fingerprinting, photo, and proof of payment of fees).

It is not yet clear how the applicant will receive the residence permit when it becomes available, whether by post to his or her home in France or by going to the Prefecture a second time.

Permit Types

Presence of less than five years

British nationals who have resided in France for less than five years as of December 31, 2020, must apply for a residence permit, depending on their status (e.g., student, employee, temporary worker, posted worker, self-employed professional, unemployed person, family member, long-term visitor). They will be issued a residence permit in accordance with the agreement bearing the specific category, such as “Withdrawal agreement—employee.”

Although the list of required documents is not yet available, applicants are advised to prepare:

  • Passport or identity card
  • Proof of address in France
  • Identity photographs
  • Proof of resources: employment contract, payslips, bank statements
  • Proof of professional activity: work certificate signed by the employer confirming the date of the start of employment in France
  • Proof of the purpose of the stay in France over the past five years (e.g., employment contract)

British nationals who have resided in France for less than five years as of December 31, 2020, can also apply for a resident card when they can prove that they have lived in France for five years. For example, a British national residing in France as of December 31, 2017, can apply for a resident card as of December 31, 2022.

Presence of five years or more

British nationals who have resided for five years or more in France as of December 31, 2020, are eligible to obtain a resident card valid for 10 years.

Although the list of required documents is not yet available, applicants are advised to prepare:

  • Passport or identity card
  • Proof of address in France
  • Three identity photographs
  • Proof of presence in France over the past five years: one document per half-year (e.g., rent receipts, energy bills)

Proof of resources: employment contract, payslips, bank statements.

For more information, please conta

Related Posts:

MALAYSIA: Companies Must Submit 2020 Employment Pass and Professional Visit Pass Projections

Companies in Malaysia registered with the Malaysia Digital Economy Corporation Sdn. Bhd. should submit their EP projections as soon as the submission period opens, which is expected to happen soon.

Due to holiday closures and the expected high volume of projection applications, companies in Malaysia registered with the Expatriate Services Division should submit their 2020 projections for Professional Visit Passes (PVP) and Employment Passes (EP) as soon as possible to avoid delays.

Companies in Malaysia registered with the Malaysia Digital Economy Corporation Sdn. Bhd. should submit their EP projections as soon as the submission period opens, which is expected to happen soon.

Although there is no deadline for submission, affected employers who do not have approved projections for 2020 cannot submit initial or renewal work pass applications until they obtain the required approval.

Foreign nationals already in Malaysia may need to exit if their new work passes cannot be obtained prior to the expiry of the current one.

Top Workforce Trends in the Global Life Sciences Industry in 2021

It has been quite a year for the entire world, but it has been a defining year for life sciences companies. Under incredible pressure and a global microscope, the industry has come out more resilient and stronger than ever, thanks in large part to incredible talent. We see six trends that show how the immense growth ties to the right global workforce. Scientific breakthroughs continue to rise, R&D dollars surge The world’s biggest life sciences companies worked together this year like never before. In a unified race to find an effective Covid-19 vaccine, information sharing across usual boundaries was required to meet the public’s most pressing health crisis. Even before the pandemic took hold, research and development spend was up 22%. Then came greater demand for innovation and partnerships amid the pandemic.    Increased investor risk and confidence Scientific breakthroughs have sustained investor enthusiasm for global life science companies. Global biopharma IPOs have raised more than $20 billion — each year bringing in more than in any previous year during the last decade, according to BioWorld data. In the first three quarters of 2019, early- and angel-/seed-stage investments accounted for around 60% of VC pharma and biotech deals, up from […]